Global Pharmaceuticals and Biotechnology R&D Market 2022 by Company, Regions, Type and Application, Forecast to 2028
The Pharmaceuticals and Biotechnology R&D market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Pharmaceuticals and Biotechnology R&D market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Pharmaceuticals and Biotechnology R&D global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Drug segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Pharmaceuticals and Biotechnology R&D include ROCHE, JOHNSON & JOHNSON, MERCK, NOVARTIS, and PFIZER, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Pharmaceuticals and Biotechnology R&D market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chapter 1, to describe Pharmaceuticals and Biotechnology R&D product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Pharmaceuticals and Biotechnology R&D, with revenue, gross margin and global market share of Pharmaceuticals and Biotechnology R&D from 2019 to 2022.
Chapter 3, the Pharmaceuticals and Biotechnology R&D competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Pharmaceuticals and Biotechnology R&D market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Pharmaceuticals and Biotechnology R&D research findings and conclusion, appendix and data source.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Pharmaceuticals and Biotechnology R&D market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Pharmaceuticals and Biotechnology R&D global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Drug segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Pharmaceuticals and Biotechnology R&D include ROCHE, JOHNSON & JOHNSON, MERCK, NOVARTIS, and PFIZER, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Pharmaceuticals and Biotechnology R&D market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
- Drug
- Medical Equipment
- Vaccine
- Others
- Hospital
- Clinic
- Homecare
- Others
- ROCHE
- JOHNSON & JOHNSON
- MERCK
- NOVARTIS
- PFIZER
- SANOFI
- BAYER
- BRISTOL-MYERS SQUIBB
- ASTRAZENECA
- GLAXOSMITHKLINE
- ABBVIE
- ELI LILLY
- BOEHRINGER SOHN
- AMGEN
- GILEAD SCIENCES
- TAKEDA PHARMACEUTICAL
- NOVO NORDISK
- BIOGEN
- ABBOTT
- ASTELLAS PHARMA
- TEVA PHARMACEUTICAL INDUSTRIES
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
- South America (Brazil, Argentina, Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Pharmaceuticals and Biotechnology R&D product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Pharmaceuticals and Biotechnology R&D, with revenue, gross margin and global market share of Pharmaceuticals and Biotechnology R&D from 2019 to 2022.
Chapter 3, the Pharmaceuticals and Biotechnology R&D competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Pharmaceuticals and Biotechnology R&D market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Pharmaceuticals and Biotechnology R&D research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Pharmaceuticals and Biotechnology R&D
1.2 Classification of Pharmaceuticals and Biotechnology R&D by Type
1.2.1 Overview: Global Pharmaceuticals and Biotechnology R&D Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Pharmaceuticals and Biotechnology R&D Revenue Market Share by Type in 2021
1.2.3 Drug
1.2.4 Medical Equipment
1.2.5 Vaccine
1.2.6 Others
1.3 Global Pharmaceuticals and Biotechnology R&D Market by Application
1.3.1 Overview: Global Pharmaceuticals and Biotechnology R&D Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Homecare
1.3.5 Others
1.4 Global Pharmaceuticals and Biotechnology R&D Market Size & Forecast
1.5 Global Pharmaceuticals and Biotechnology R&D Market Size and Forecast by Region
1.5.1 Global Pharmaceuticals and Biotechnology R&D Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Pharmaceuticals and Biotechnology R&D Market Size by Region, (2017-2022)
1.5.3 North America Pharmaceuticals and Biotechnology R&D Market Size and Prospect (2017-2028)
1.5.4 Europe Pharmaceuticals and Biotechnology R&D Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size and Prospect (2017-2028)
1.5.6 South America Pharmaceuticals and Biotechnology R&D Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Pharmaceuticals and Biotechnology R&D Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Pharmaceuticals and Biotechnology R&D Market Drivers
1.6.2 Pharmaceuticals and Biotechnology R&D Market Restraints
1.6.3 Pharmaceuticals and Biotechnology R&D Trends Analysis
2 COMPANY PROFILES
2.1 ROCHE
2.1.1 ROCHE Details
2.1.2 ROCHE Major Business
2.1.3 ROCHE Pharmaceuticals and Biotechnology R&D Product and Solutions
2.1.4 ROCHE Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 ROCHE Recent Developments and Future Plans
2.2 JOHNSON & JOHNSON
2.2.1 JOHNSON & JOHNSON Details
2.2.2 JOHNSON & JOHNSON Major Business
2.2.3 JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R&D Product and Solutions
2.2.4 JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 JOHNSON & JOHNSON Recent Developments and Future Plans
2.3 MERCK
2.3.1 MERCK Details
2.3.2 MERCK Major Business
2.3.3 MERCK Pharmaceuticals and Biotechnology R&D Product and Solutions
2.3.4 MERCK Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 MERCK Recent Developments and Future Plans
2.4 NOVARTIS
2.4.1 NOVARTIS Details
2.4.2 NOVARTIS Major Business
2.4.3 NOVARTIS Pharmaceuticals and Biotechnology R&D Product and Solutions
2.4.4 NOVARTIS Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 NOVARTIS Recent Developments and Future Plans
2.5 PFIZER
2.5.1 PFIZER Details
2.5.2 PFIZER Major Business
2.5.3 PFIZER Pharmaceuticals and Biotechnology R&D Product and Solutions
2.5.4 PFIZER Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 PFIZER Recent Developments and Future Plans
2.6 SANOFI
2.6.1 SANOFI Details
2.6.2 SANOFI Major Business
2.6.3 SANOFI Pharmaceuticals and Biotechnology R&D Product and Solutions
2.6.4 SANOFI Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 SANOFI Recent Developments and Future Plans
2.7 BAYER
2.7.1 BAYER Details
2.7.2 BAYER Major Business
2.7.3 BAYER Pharmaceuticals and Biotechnology R&D Product and Solutions
2.7.4 BAYER Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 BAYER Recent Developments and Future Plans
2.8 BRISTOL-MYERS SQUIBB
2.8.1 BRISTOL-MYERS SQUIBB Details
2.8.2 BRISTOL-MYERS SQUIBB Major Business
2.8.3 BRISTOL-MYERS SQUIBB Pharmaceuticals and Biotechnology R&D Product and Solutions
2.8.4 BRISTOL-MYERS SQUIBB Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 BRISTOL-MYERS SQUIBB Recent Developments and Future Plans
2.9 ASTRAZENECA
2.9.1 ASTRAZENECA Details
2.9.2 ASTRAZENECA Major Business
2.9.3 ASTRAZENECA Pharmaceuticals and Biotechnology R&D Product and Solutions
2.9.4 ASTRAZENECA Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 ASTRAZENECA Recent Developments and Future Plans
2.10 GLAXOSMITHKLINE
2.10.1 GLAXOSMITHKLINE Details
2.10.2 GLAXOSMITHKLINE Major Business
2.10.3 GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R&D Product and Solutions
2.10.4 GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 GLAXOSMITHKLINE Recent Developments and Future Plans
2.11 ABBVIE
2.11.1 ABBVIE Details
2.11.2 ABBVIE Major Business
2.11.3 ABBVIE Pharmaceuticals and Biotechnology R&D Product and Solutions
2.11.4 ABBVIE Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 ABBVIE Recent Developments and Future Plans
2.12 ELI LILLY
2.12.1 ELI LILLY Details
2.12.2 ELI LILLY Major Business
2.12.3 ELI LILLY Pharmaceuticals and Biotechnology R&D Product and Solutions
2.12.4 ELI LILLY Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 ELI LILLY Recent Developments and Future Plans
2.13 BOEHRINGER SOHN
2.13.1 BOEHRINGER SOHN Details
2.13.2 BOEHRINGER SOHN Major Business
2.13.3 BOEHRINGER SOHN Pharmaceuticals and Biotechnology R&D Product and Solutions
2.13.4 BOEHRINGER SOHN Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 BOEHRINGER SOHN Recent Developments and Future Plans
2.14 AMGEN
2.14.1 AMGEN Details
2.14.2 AMGEN Major Business
2.14.3 AMGEN Pharmaceuticals and Biotechnology R&D Product and Solutions
2.14.4 AMGEN Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 AMGEN Recent Developments and Future Plans
2.15 GILEAD SCIENCES
2.15.1 GILEAD SCIENCES Details
2.15.2 GILEAD SCIENCES Major Business
2.15.3 GILEAD SCIENCES Pharmaceuticals and Biotechnology R&D Product and Solutions
2.15.4 GILEAD SCIENCES Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 GILEAD SCIENCES Recent Developments and Future Plans
2.16 TAKEDA PHARMACEUTICAL
2.16.1 TAKEDA PHARMACEUTICAL Details
2.16.2 TAKEDA PHARMACEUTICAL Major Business
2.16.3 TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R&D Product and Solutions
2.16.4 TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 TAKEDA PHARMACEUTICAL Recent Developments and Future Plans
2.17 NOVO NORDISK
2.17.1 NOVO NORDISK Details
2.17.2 NOVO NORDISK Major Business
2.17.3 NOVO NORDISK Pharmaceuticals and Biotechnology R&D Product and Solutions
2.17.4 NOVO NORDISK Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 NOVO NORDISK Recent Developments and Future Plans
2.18 BIOGEN
2.18.1 BIOGEN Details
2.18.2 BIOGEN Major Business
2.18.3 BIOGEN Pharmaceuticals and Biotechnology R&D Product and Solutions
2.18.4 BIOGEN Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18.5 BIOGEN Recent Developments and Future Plans
2.19 ABBOTT
2.19.1 ABBOTT Details
2.19.2 ABBOTT Major Business
2.19.3 ABBOTT Pharmaceuticals and Biotechnology R&D Product and Solutions
2.19.4 ABBOTT Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19.5 ABBOTT Recent Developments and Future Plans
2.20 ASTELLAS PHARMA
2.20.1 ASTELLAS PHARMA Details
2.20.2 ASTELLAS PHARMA Major Business
2.20.3 ASTELLAS PHARMA Pharmaceuticals and Biotechnology R&D Product and Solutions
2.20.4 ASTELLAS PHARMA Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20.5 ASTELLAS PHARMA Recent Developments and Future Plans
2.21 TEVA PHARMACEUTICAL INDUSTRIES
2.21.1 TEVA PHARMACEUTICAL INDUSTRIES Details
2.21.2 TEVA PHARMACEUTICAL INDUSTRIES Major Business
2.21.3 TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R&D Product and Solutions
2.21.4 TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21.5 TEVA PHARMACEUTICAL INDUSTRIES Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Pharmaceuticals and Biotechnology R&D Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Pharmaceuticals and Biotechnology R&D Players Market Share in 2021
3.2.2 Top 10 Pharmaceuticals and Biotechnology R&D Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Pharmaceuticals and Biotechnology R&D Players Head Office, Products and Services Provided
3.4 Pharmaceuticals and Biotechnology R&D Mergers & Acquisitions
3.5 Pharmaceuticals and Biotechnology R&D New Entrants and Expansion Plans
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Pharmaceuticals and Biotechnology R&D Revenue and Market Share by Type (2017-2022)
4.2 Global Pharmaceuticals and Biotechnology R&D Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Pharmaceuticals and Biotechnology R&D Revenue Market Share by Application (2017-2022)
5.2 Global Pharmaceuticals and Biotechnology R&D Market Forecast by Application (2023-2028)
6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
6.1 North America Pharmaceuticals and Biotechnology R&D Revenue by Type (2017-2028)
6.2 North America Pharmaceuticals and Biotechnology R&D Revenue by Application (2017-2028)
6.3 North America Pharmaceuticals and Biotechnology R&D Market Size by Country
6.3.1 North America Pharmaceuticals and Biotechnology R&D Revenue by Country (2017-2028)
6.3.2 United States Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2017-2028)
6.3.3 Canada Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2017-2028)
6.3.4 Mexico Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2017-2028)
7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 Europe Pharmaceuticals and Biotechnology R&D Revenue by Type (2017-2028)
7.2 Europe Pharmaceuticals and Biotechnology R&D Revenue by Application (2017-2028)
7.3 Europe Pharmaceuticals and Biotechnology R&D Market Size by Country
7.3.1 Europe Pharmaceuticals and Biotechnology R&D Revenue by Country (2017-2028)
7.3.2 Germany Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2017-2028)
7.3.3 France Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2017-2028)
7.3.5 Russia Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2017-2028)
7.3.6 Italy Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
8.1 Asia-Pacific Pharmaceuticals and Biotechnology R&D Revenue by Type (2017-2028)
8.2 Asia-Pacific Pharmaceuticals and Biotechnology R&D Revenue by Application (2017-2028)
8.3 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Region
8.3.1 Asia-Pacific Pharmaceuticals and Biotechnology R&D Revenue by Region (2017-2028)
8.3.2 China Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2017-2028)
8.3.3 Japan Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2017-2028)
8.3.4 South Korea Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2017-2028)
8.3.5 India Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2017-2028)
8.3.7 Australia Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2017-2028)
9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 South America Pharmaceuticals and Biotechnology R&D Revenue by Type (2017-2028)
9.2 South America Pharmaceuticals and Biotechnology R&D Revenue by Application (2017-2028)
9.3 South America Pharmaceuticals and Biotechnology R&D Market Size by Country
9.3.1 South America Pharmaceuticals and Biotechnology R&D Revenue by Country (2017-2028)
9.3.2 Brazil Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2017-2028)
9.3.3 Argentina Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 Middle East & Africa Pharmaceuticals and Biotechnology R&D Revenue by Type (2017-2028)
10.2 Middle East & Africa Pharmaceuticals and Biotechnology R&D Revenue by Application (2017-2028)
10.3 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Country
10.3.1 Middle East & Africa Pharmaceuticals and Biotechnology R&D Revenue by Country (2017-2028)
10.3.2 Turkey Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2017-2028)
10.3.4 UAE Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2017-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Product Overview and Scope of Pharmaceuticals and Biotechnology R&D
1.2 Classification of Pharmaceuticals and Biotechnology R&D by Type
1.2.1 Overview: Global Pharmaceuticals and Biotechnology R&D Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Pharmaceuticals and Biotechnology R&D Revenue Market Share by Type in 2021
1.2.3 Drug
1.2.4 Medical Equipment
1.2.5 Vaccine
1.2.6 Others
1.3 Global Pharmaceuticals and Biotechnology R&D Market by Application
1.3.1 Overview: Global Pharmaceuticals and Biotechnology R&D Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Homecare
1.3.5 Others
1.4 Global Pharmaceuticals and Biotechnology R&D Market Size & Forecast
1.5 Global Pharmaceuticals and Biotechnology R&D Market Size and Forecast by Region
1.5.1 Global Pharmaceuticals and Biotechnology R&D Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Pharmaceuticals and Biotechnology R&D Market Size by Region, (2017-2022)
1.5.3 North America Pharmaceuticals and Biotechnology R&D Market Size and Prospect (2017-2028)
1.5.4 Europe Pharmaceuticals and Biotechnology R&D Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size and Prospect (2017-2028)
1.5.6 South America Pharmaceuticals and Biotechnology R&D Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Pharmaceuticals and Biotechnology R&D Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Pharmaceuticals and Biotechnology R&D Market Drivers
1.6.2 Pharmaceuticals and Biotechnology R&D Market Restraints
1.6.3 Pharmaceuticals and Biotechnology R&D Trends Analysis
2 COMPANY PROFILES
2.1 ROCHE
2.1.1 ROCHE Details
2.1.2 ROCHE Major Business
2.1.3 ROCHE Pharmaceuticals and Biotechnology R&D Product and Solutions
2.1.4 ROCHE Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 ROCHE Recent Developments and Future Plans
2.2 JOHNSON & JOHNSON
2.2.1 JOHNSON & JOHNSON Details
2.2.2 JOHNSON & JOHNSON Major Business
2.2.3 JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R&D Product and Solutions
2.2.4 JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 JOHNSON & JOHNSON Recent Developments and Future Plans
2.3 MERCK
2.3.1 MERCK Details
2.3.2 MERCK Major Business
2.3.3 MERCK Pharmaceuticals and Biotechnology R&D Product and Solutions
2.3.4 MERCK Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 MERCK Recent Developments and Future Plans
2.4 NOVARTIS
2.4.1 NOVARTIS Details
2.4.2 NOVARTIS Major Business
2.4.3 NOVARTIS Pharmaceuticals and Biotechnology R&D Product and Solutions
2.4.4 NOVARTIS Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 NOVARTIS Recent Developments and Future Plans
2.5 PFIZER
2.5.1 PFIZER Details
2.5.2 PFIZER Major Business
2.5.3 PFIZER Pharmaceuticals and Biotechnology R&D Product and Solutions
2.5.4 PFIZER Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 PFIZER Recent Developments and Future Plans
2.6 SANOFI
2.6.1 SANOFI Details
2.6.2 SANOFI Major Business
2.6.3 SANOFI Pharmaceuticals and Biotechnology R&D Product and Solutions
2.6.4 SANOFI Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 SANOFI Recent Developments and Future Plans
2.7 BAYER
2.7.1 BAYER Details
2.7.2 BAYER Major Business
2.7.3 BAYER Pharmaceuticals and Biotechnology R&D Product and Solutions
2.7.4 BAYER Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 BAYER Recent Developments and Future Plans
2.8 BRISTOL-MYERS SQUIBB
2.8.1 BRISTOL-MYERS SQUIBB Details
2.8.2 BRISTOL-MYERS SQUIBB Major Business
2.8.3 BRISTOL-MYERS SQUIBB Pharmaceuticals and Biotechnology R&D Product and Solutions
2.8.4 BRISTOL-MYERS SQUIBB Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 BRISTOL-MYERS SQUIBB Recent Developments and Future Plans
2.9 ASTRAZENECA
2.9.1 ASTRAZENECA Details
2.9.2 ASTRAZENECA Major Business
2.9.3 ASTRAZENECA Pharmaceuticals and Biotechnology R&D Product and Solutions
2.9.4 ASTRAZENECA Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 ASTRAZENECA Recent Developments and Future Plans
2.10 GLAXOSMITHKLINE
2.10.1 GLAXOSMITHKLINE Details
2.10.2 GLAXOSMITHKLINE Major Business
2.10.3 GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R&D Product and Solutions
2.10.4 GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 GLAXOSMITHKLINE Recent Developments and Future Plans
2.11 ABBVIE
2.11.1 ABBVIE Details
2.11.2 ABBVIE Major Business
2.11.3 ABBVIE Pharmaceuticals and Biotechnology R&D Product and Solutions
2.11.4 ABBVIE Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 ABBVIE Recent Developments and Future Plans
2.12 ELI LILLY
2.12.1 ELI LILLY Details
2.12.2 ELI LILLY Major Business
2.12.3 ELI LILLY Pharmaceuticals and Biotechnology R&D Product and Solutions
2.12.4 ELI LILLY Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 ELI LILLY Recent Developments and Future Plans
2.13 BOEHRINGER SOHN
2.13.1 BOEHRINGER SOHN Details
2.13.2 BOEHRINGER SOHN Major Business
2.13.3 BOEHRINGER SOHN Pharmaceuticals and Biotechnology R&D Product and Solutions
2.13.4 BOEHRINGER SOHN Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 BOEHRINGER SOHN Recent Developments and Future Plans
2.14 AMGEN
2.14.1 AMGEN Details
2.14.2 AMGEN Major Business
2.14.3 AMGEN Pharmaceuticals and Biotechnology R&D Product and Solutions
2.14.4 AMGEN Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 AMGEN Recent Developments and Future Plans
2.15 GILEAD SCIENCES
2.15.1 GILEAD SCIENCES Details
2.15.2 GILEAD SCIENCES Major Business
2.15.3 GILEAD SCIENCES Pharmaceuticals and Biotechnology R&D Product and Solutions
2.15.4 GILEAD SCIENCES Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 GILEAD SCIENCES Recent Developments and Future Plans
2.16 TAKEDA PHARMACEUTICAL
2.16.1 TAKEDA PHARMACEUTICAL Details
2.16.2 TAKEDA PHARMACEUTICAL Major Business
2.16.3 TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R&D Product and Solutions
2.16.4 TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 TAKEDA PHARMACEUTICAL Recent Developments and Future Plans
2.17 NOVO NORDISK
2.17.1 NOVO NORDISK Details
2.17.2 NOVO NORDISK Major Business
2.17.3 NOVO NORDISK Pharmaceuticals and Biotechnology R&D Product and Solutions
2.17.4 NOVO NORDISK Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 NOVO NORDISK Recent Developments and Future Plans
2.18 BIOGEN
2.18.1 BIOGEN Details
2.18.2 BIOGEN Major Business
2.18.3 BIOGEN Pharmaceuticals and Biotechnology R&D Product and Solutions
2.18.4 BIOGEN Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18.5 BIOGEN Recent Developments and Future Plans
2.19 ABBOTT
2.19.1 ABBOTT Details
2.19.2 ABBOTT Major Business
2.19.3 ABBOTT Pharmaceuticals and Biotechnology R&D Product and Solutions
2.19.4 ABBOTT Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19.5 ABBOTT Recent Developments and Future Plans
2.20 ASTELLAS PHARMA
2.20.1 ASTELLAS PHARMA Details
2.20.2 ASTELLAS PHARMA Major Business
2.20.3 ASTELLAS PHARMA Pharmaceuticals and Biotechnology R&D Product and Solutions
2.20.4 ASTELLAS PHARMA Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20.5 ASTELLAS PHARMA Recent Developments and Future Plans
2.21 TEVA PHARMACEUTICAL INDUSTRIES
2.21.1 TEVA PHARMACEUTICAL INDUSTRIES Details
2.21.2 TEVA PHARMACEUTICAL INDUSTRIES Major Business
2.21.3 TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R&D Product and Solutions
2.21.4 TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21.5 TEVA PHARMACEUTICAL INDUSTRIES Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Pharmaceuticals and Biotechnology R&D Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Pharmaceuticals and Biotechnology R&D Players Market Share in 2021
3.2.2 Top 10 Pharmaceuticals and Biotechnology R&D Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Pharmaceuticals and Biotechnology R&D Players Head Office, Products and Services Provided
3.4 Pharmaceuticals and Biotechnology R&D Mergers & Acquisitions
3.5 Pharmaceuticals and Biotechnology R&D New Entrants and Expansion Plans
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Pharmaceuticals and Biotechnology R&D Revenue and Market Share by Type (2017-2022)
4.2 Global Pharmaceuticals and Biotechnology R&D Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Pharmaceuticals and Biotechnology R&D Revenue Market Share by Application (2017-2022)
5.2 Global Pharmaceuticals and Biotechnology R&D Market Forecast by Application (2023-2028)
6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
6.1 North America Pharmaceuticals and Biotechnology R&D Revenue by Type (2017-2028)
6.2 North America Pharmaceuticals and Biotechnology R&D Revenue by Application (2017-2028)
6.3 North America Pharmaceuticals and Biotechnology R&D Market Size by Country
6.3.1 North America Pharmaceuticals and Biotechnology R&D Revenue by Country (2017-2028)
6.3.2 United States Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2017-2028)
6.3.3 Canada Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2017-2028)
6.3.4 Mexico Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2017-2028)
7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 Europe Pharmaceuticals and Biotechnology R&D Revenue by Type (2017-2028)
7.2 Europe Pharmaceuticals and Biotechnology R&D Revenue by Application (2017-2028)
7.3 Europe Pharmaceuticals and Biotechnology R&D Market Size by Country
7.3.1 Europe Pharmaceuticals and Biotechnology R&D Revenue by Country (2017-2028)
7.3.2 Germany Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2017-2028)
7.3.3 France Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2017-2028)
7.3.5 Russia Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2017-2028)
7.3.6 Italy Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
8.1 Asia-Pacific Pharmaceuticals and Biotechnology R&D Revenue by Type (2017-2028)
8.2 Asia-Pacific Pharmaceuticals and Biotechnology R&D Revenue by Application (2017-2028)
8.3 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Region
8.3.1 Asia-Pacific Pharmaceuticals and Biotechnology R&D Revenue by Region (2017-2028)
8.3.2 China Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2017-2028)
8.3.3 Japan Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2017-2028)
8.3.4 South Korea Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2017-2028)
8.3.5 India Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2017-2028)
8.3.7 Australia Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2017-2028)
9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 South America Pharmaceuticals and Biotechnology R&D Revenue by Type (2017-2028)
9.2 South America Pharmaceuticals and Biotechnology R&D Revenue by Application (2017-2028)
9.3 South America Pharmaceuticals and Biotechnology R&D Market Size by Country
9.3.1 South America Pharmaceuticals and Biotechnology R&D Revenue by Country (2017-2028)
9.3.2 Brazil Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2017-2028)
9.3.3 Argentina Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 Middle East & Africa Pharmaceuticals and Biotechnology R&D Revenue by Type (2017-2028)
10.2 Middle East & Africa Pharmaceuticals and Biotechnology R&D Revenue by Application (2017-2028)
10.3 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Country
10.3.1 Middle East & Africa Pharmaceuticals and Biotechnology R&D Revenue by Country (2017-2028)
10.3.2 Turkey Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2017-2028)
10.3.4 UAE Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2017-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. Global Pharmaceuticals and Biotechnology R&D Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Pharmaceuticals and Biotechnology R&D Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Pharmaceuticals and Biotechnology R&D Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Pharmaceuticals and Biotechnology R&D Revenue (USD Million) by Region (2017-2022)
Table 5. Global Pharmaceuticals and Biotechnology R&D Revenue Market Share by Region (2023-2028)
Table 6. ROCHE Corporate Information, Head Office, and Major Competitors
Table 7. ROCHE Major Business
Table 8. ROCHE Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 9. ROCHE Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. JOHNSON & JOHNSON Corporate Information, Head Office, and Major Competitors
Table 11. JOHNSON & JOHNSON Major Business
Table 12. JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 13. JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. MERCK Corporate Information, Head Office, and Major Competitors
Table 15. MERCK Major Business
Table 16. MERCK Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 17. MERCK Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. NOVARTIS Corporate Information, Head Office, and Major Competitors
Table 19. NOVARTIS Major Business
Table 20. NOVARTIS Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 21. NOVARTIS Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. PFIZER Corporate Information, Head Office, and Major Competitors
Table 23. PFIZER Major Business
Table 24. PFIZER Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 25. PFIZER Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. SANOFI Corporate Information, Head Office, and Major Competitors
Table 27. SANOFI Major Business
Table 28. SANOFI Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 29. SANOFI Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. BAYER Corporate Information, Head Office, and Major Competitors
Table 31. BAYER Major Business
Table 32. BAYER Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 33. BAYER Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. BRISTOL-MYERS SQUIBB Corporate Information, Head Office, and Major Competitors
Table 35. BRISTOL-MYERS SQUIBB Major Business
Table 36. BRISTOL-MYERS SQUIBB Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 37. BRISTOL-MYERS SQUIBB Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. ASTRAZENECA Corporate Information, Head Office, and Major Competitors
Table 39. ASTRAZENECA Major Business
Table 40. ASTRAZENECA Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 41. ASTRAZENECA Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. GLAXOSMITHKLINE Corporate Information, Head Office, and Major Competitors
Table 43. GLAXOSMITHKLINE Major Business
Table 44. GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 45. GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. ABBVIE Corporate Information, Head Office, and Major Competitors
Table 47. ABBVIE Major Business
Table 48. ABBVIE Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 49. ABBVIE Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. ELI LILLY Corporate Information, Head Office, and Major Competitors
Table 51. ELI LILLY Major Business
Table 52. ELI LILLY Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 53. ELI LILLY Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. BOEHRINGER SOHN Corporate Information, Head Office, and Major Competitors
Table 55. BOEHRINGER SOHN Major Business
Table 56. BOEHRINGER SOHN Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 57. BOEHRINGER SOHN Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. AMGEN Corporate Information, Head Office, and Major Competitors
Table 59. AMGEN Major Business
Table 60. AMGEN Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 61. AMGEN Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. GILEAD SCIENCES Corporate Information, Head Office, and Major Competitors
Table 63. GILEAD SCIENCES Major Business
Table 64. GILEAD SCIENCES Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 65. GILEAD SCIENCES Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. TAKEDA PHARMACEUTICAL Corporate Information, Head Office, and Major Competitors
Table 67. TAKEDA PHARMACEUTICAL Major Business
Table 68. TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 69. TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. NOVO NORDISK Corporate Information, Head Office, and Major Competitors
Table 71. NOVO NORDISK Major Business
Table 72. NOVO NORDISK Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 73. NOVO NORDISK Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. BIOGEN Corporate Information, Head Office, and Major Competitors
Table 75. BIOGEN Major Business
Table 76. BIOGEN Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 77. BIOGEN Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 78. ABBOTT Corporate Information, Head Office, and Major Competitors
Table 79. ABBOTT Major Business
Table 80. ABBOTT Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 81. ABBOTT Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 82. ASTELLAS PHARMA Corporate Information, Head Office, and Major Competitors
Table 83. ASTELLAS PHARMA Major Business
Table 84. ASTELLAS PHARMA Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 85. ASTELLAS PHARMA Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 86. TEVA PHARMACEUTICAL INDUSTRIES Corporate Information, Head Office, and Major Competitors
Table 87. TEVA PHARMACEUTICAL INDUSTRIES Major Business
Table 88. TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 89. TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 90. Global Pharmaceuticals and Biotechnology R&D Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 91. Global Pharmaceuticals and Biotechnology R&D Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 92. Breakdown of Pharmaceuticals and Biotechnology R&D by Company Type (Tier 1, Tier 2 and Tier 3)
Table 93. Pharmaceuticals and Biotechnology R&D Players Head Office, Products and Services Provided
Table 94. Pharmaceuticals and Biotechnology R&D Mergers & Acquisitions in the Past Five Years
Table 95. Pharmaceuticals and Biotechnology R&D New Entrants and Expansion Plans
Table 96. Global Pharmaceuticals and Biotechnology R&D Revenue (USD Million) by Type (2017-2022)
Table 97. Global Pharmaceuticals and Biotechnology R&D Revenue Share by Type (2017-2022)
Table 98. Global Pharmaceuticals and Biotechnology R&D Revenue Forecast by Type (2023-2028)
Table 99. Global Pharmaceuticals and Biotechnology R&D Revenue by Application (2017-2022)
Table 100. Global Pharmaceuticals and Biotechnology R&D Revenue Forecast by Application (2023-2028)
Table 101. North America Pharmaceuticals and Biotechnology R&D Revenue by Type (2017-2022) & (USD Million)
Table 102. North America Pharmaceuticals and Biotechnology R&D Revenue by Type (2023-2028) & (USD Million)
Table 103. North America Pharmaceuticals and Biotechnology R&D Revenue by Application (2017-2022) & (USD Million)
Table 104. North America Pharmaceuticals and Biotechnology R&D Revenue by Application (2023-2028) & (USD Million)
Table 105. North America Pharmaceuticals and Biotechnology R&D Revenue by Country (2017-2022) & (USD Million)
Table 106. North America Pharmaceuticals and Biotechnology R&D Revenue by Country (2023-2028) & (USD Million)
Table 107. Europe Pharmaceuticals and Biotechnology R&D Revenue by Type (2017-2022) & (USD Million)
Table 108. Europe Pharmaceuticals and Biotechnology R&D Revenue by Type (2023-2028) & (USD Million)
Table 109. Europe Pharmaceuticals and Biotechnology R&D Revenue by Application (2017-2022) & (USD Million)
Table 110. Europe Pharmaceuticals and Biotechnology R&D Revenue by Application (2023-2028) & (USD Million)
Table 111. Europe Pharmaceuticals and Biotechnology R&D Revenue by Country (2017-2022) & (USD Million)
Table 112. Europe Pharmaceuticals and Biotechnology R&D Revenue by Country (2023-2028) & (USD Million)
Table 113. Asia-Pacific Pharmaceuticals and Biotechnology R&D Revenue by Type (2017-2022) & (USD Million)
Table 114. Asia-Pacific Pharmaceuticals and Biotechnology R&D Revenue by Type (2023-2028) & (USD Million)
Table 115. Asia-Pacific Pharmaceuticals and Biotechnology R&D Revenue by Application (2017-2022) & (USD Million)
Table 116. Asia-Pacific Pharmaceuticals and Biotechnology R&D Revenue by Application (2023-2028) & (USD Million)
Table 117. Asia-Pacific Pharmaceuticals and Biotechnology R&D Revenue by Region (2017-2022) & (USD Million)
Table 118. Asia-Pacific Pharmaceuticals and Biotechnology R&D Revenue by Region (2023-2028) & (USD Million)
Table 119. South America Pharmaceuticals and Biotechnology R&D Revenue by Type (2017-2022) & (USD Million)
Table 120. South America Pharmaceuticals and Biotechnology R&D Revenue by Type (2023-2028) & (USD Million)
Table 121. South America Pharmaceuticals and Biotechnology R&D Revenue by Application (2017-2022) & (USD Million)
Table 122. South America Pharmaceuticals and Biotechnology R&D Revenue by Application (2023-2028) & (USD Million)
Table 123. South America Pharmaceuticals and Biotechnology R&D Revenue by Country (2017-2022) & (USD Million)
Table 124. South America Pharmaceuticals and Biotechnology R&D Revenue by Country (2023-2028) & (USD Million)
Table 125. Middle East & Africa Pharmaceuticals and Biotechnology R&D Revenue by Type (2017-2022) & (USD Million)
Table 126. Middle East & Africa Pharmaceuticals and Biotechnology R&D Revenue by Type (2023-2028) & (USD Million)
Table 127. Middle East & Africa Pharmaceuticals and Biotechnology R&D Revenue by Application (2017-2022) & (USD Million)
Table 128. Middle East & Africa Pharmaceuticals and Biotechnology R&D Revenue by Application (2023-2028) & (USD Million)
Table 129. Middle East & Africa Pharmaceuticals and Biotechnology R&D Revenue by Country (2017-2022) & (USD Million)
Table 130. Middle East & Africa Pharmaceuticals and Biotechnology R&D Revenue by Country (2023-2028) & (USD Million)
Table 1. Global Pharmaceuticals and Biotechnology R&D Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Pharmaceuticals and Biotechnology R&D Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Pharmaceuticals and Biotechnology R&D Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Pharmaceuticals and Biotechnology R&D Revenue (USD Million) by Region (2017-2022)
Table 5. Global Pharmaceuticals and Biotechnology R&D Revenue Market Share by Region (2023-2028)
Table 6. ROCHE Corporate Information, Head Office, and Major Competitors
Table 7. ROCHE Major Business
Table 8. ROCHE Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 9. ROCHE Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. JOHNSON & JOHNSON Corporate Information, Head Office, and Major Competitors
Table 11. JOHNSON & JOHNSON Major Business
Table 12. JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 13. JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. MERCK Corporate Information, Head Office, and Major Competitors
Table 15. MERCK Major Business
Table 16. MERCK Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 17. MERCK Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. NOVARTIS Corporate Information, Head Office, and Major Competitors
Table 19. NOVARTIS Major Business
Table 20. NOVARTIS Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 21. NOVARTIS Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. PFIZER Corporate Information, Head Office, and Major Competitors
Table 23. PFIZER Major Business
Table 24. PFIZER Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 25. PFIZER Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. SANOFI Corporate Information, Head Office, and Major Competitors
Table 27. SANOFI Major Business
Table 28. SANOFI Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 29. SANOFI Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. BAYER Corporate Information, Head Office, and Major Competitors
Table 31. BAYER Major Business
Table 32. BAYER Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 33. BAYER Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. BRISTOL-MYERS SQUIBB Corporate Information, Head Office, and Major Competitors
Table 35. BRISTOL-MYERS SQUIBB Major Business
Table 36. BRISTOL-MYERS SQUIBB Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 37. BRISTOL-MYERS SQUIBB Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. ASTRAZENECA Corporate Information, Head Office, and Major Competitors
Table 39. ASTRAZENECA Major Business
Table 40. ASTRAZENECA Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 41. ASTRAZENECA Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. GLAXOSMITHKLINE Corporate Information, Head Office, and Major Competitors
Table 43. GLAXOSMITHKLINE Major Business
Table 44. GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 45. GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. ABBVIE Corporate Information, Head Office, and Major Competitors
Table 47. ABBVIE Major Business
Table 48. ABBVIE Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 49. ABBVIE Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. ELI LILLY Corporate Information, Head Office, and Major Competitors
Table 51. ELI LILLY Major Business
Table 52. ELI LILLY Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 53. ELI LILLY Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. BOEHRINGER SOHN Corporate Information, Head Office, and Major Competitors
Table 55. BOEHRINGER SOHN Major Business
Table 56. BOEHRINGER SOHN Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 57. BOEHRINGER SOHN Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. AMGEN Corporate Information, Head Office, and Major Competitors
Table 59. AMGEN Major Business
Table 60. AMGEN Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 61. AMGEN Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. GILEAD SCIENCES Corporate Information, Head Office, and Major Competitors
Table 63. GILEAD SCIENCES Major Business
Table 64. GILEAD SCIENCES Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 65. GILEAD SCIENCES Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. TAKEDA PHARMACEUTICAL Corporate Information, Head Office, and Major Competitors
Table 67. TAKEDA PHARMACEUTICAL Major Business
Table 68. TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 69. TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. NOVO NORDISK Corporate Information, Head Office, and Major Competitors
Table 71. NOVO NORDISK Major Business
Table 72. NOVO NORDISK Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 73. NOVO NORDISK Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. BIOGEN Corporate Information, Head Office, and Major Competitors
Table 75. BIOGEN Major Business
Table 76. BIOGEN Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 77. BIOGEN Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 78. ABBOTT Corporate Information, Head Office, and Major Competitors
Table 79. ABBOTT Major Business
Table 80. ABBOTT Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 81. ABBOTT Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 82. ASTELLAS PHARMA Corporate Information, Head Office, and Major Competitors
Table 83. ASTELLAS PHARMA Major Business
Table 84. ASTELLAS PHARMA Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 85. ASTELLAS PHARMA Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 86. TEVA PHARMACEUTICAL INDUSTRIES Corporate Information, Head Office, and Major Competitors
Table 87. TEVA PHARMACEUTICAL INDUSTRIES Major Business
Table 88. TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R&D Product and Solutions
Table 89. TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 90. Global Pharmaceuticals and Biotechnology R&D Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 91. Global Pharmaceuticals and Biotechnology R&D Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 92. Breakdown of Pharmaceuticals and Biotechnology R&D by Company Type (Tier 1, Tier 2 and Tier 3)
Table 93. Pharmaceuticals and Biotechnology R&D Players Head Office, Products and Services Provided
Table 94. Pharmaceuticals and Biotechnology R&D Mergers & Acquisitions in the Past Five Years
Table 95. Pharmaceuticals and Biotechnology R&D New Entrants and Expansion Plans
Table 96. Global Pharmaceuticals and Biotechnology R&D Revenue (USD Million) by Type (2017-2022)
Table 97. Global Pharmaceuticals and Biotechnology R&D Revenue Share by Type (2017-2022)
Table 98. Global Pharmaceuticals and Biotechnology R&D Revenue Forecast by Type (2023-2028)
Table 99. Global Pharmaceuticals and Biotechnology R&D Revenue by Application (2017-2022)
Table 100. Global Pharmaceuticals and Biotechnology R&D Revenue Forecast by Application (2023-2028)
Table 101. North America Pharmaceuticals and Biotechnology R&D Revenue by Type (2017-2022) & (USD Million)
Table 102. North America Pharmaceuticals and Biotechnology R&D Revenue by Type (2023-2028) & (USD Million)
Table 103. North America Pharmaceuticals and Biotechnology R&D Revenue by Application (2017-2022) & (USD Million)
Table 104. North America Pharmaceuticals and Biotechnology R&D Revenue by Application (2023-2028) & (USD Million)
Table 105. North America Pharmaceuticals and Biotechnology R&D Revenue by Country (2017-2022) & (USD Million)
Table 106. North America Pharmaceuticals and Biotechnology R&D Revenue by Country (2023-2028) & (USD Million)
Table 107. Europe Pharmaceuticals and Biotechnology R&D Revenue by Type (2017-2022) & (USD Million)
Table 108. Europe Pharmaceuticals and Biotechnology R&D Revenue by Type (2023-2028) & (USD Million)
Table 109. Europe Pharmaceuticals and Biotechnology R&D Revenue by Application (2017-2022) & (USD Million)
Table 110. Europe Pharmaceuticals and Biotechnology R&D Revenue by Application (2023-2028) & (USD Million)
Table 111. Europe Pharmaceuticals and Biotechnology R&D Revenue by Country (2017-2022) & (USD Million)
Table 112. Europe Pharmaceuticals and Biotechnology R&D Revenue by Country (2023-2028) & (USD Million)
Table 113. Asia-Pacific Pharmaceuticals and Biotechnology R&D Revenue by Type (2017-2022) & (USD Million)
Table 114. Asia-Pacific Pharmaceuticals and Biotechnology R&D Revenue by Type (2023-2028) & (USD Million)
Table 115. Asia-Pacific Pharmaceuticals and Biotechnology R&D Revenue by Application (2017-2022) & (USD Million)
Table 116. Asia-Pacific Pharmaceuticals and Biotechnology R&D Revenue by Application (2023-2028) & (USD Million)
Table 117. Asia-Pacific Pharmaceuticals and Biotechnology R&D Revenue by Region (2017-2022) & (USD Million)
Table 118. Asia-Pacific Pharmaceuticals and Biotechnology R&D Revenue by Region (2023-2028) & (USD Million)
Table 119. South America Pharmaceuticals and Biotechnology R&D Revenue by Type (2017-2022) & (USD Million)
Table 120. South America Pharmaceuticals and Biotechnology R&D Revenue by Type (2023-2028) & (USD Million)
Table 121. South America Pharmaceuticals and Biotechnology R&D Revenue by Application (2017-2022) & (USD Million)
Table 122. South America Pharmaceuticals and Biotechnology R&D Revenue by Application (2023-2028) & (USD Million)
Table 123. South America Pharmaceuticals and Biotechnology R&D Revenue by Country (2017-2022) & (USD Million)
Table 124. South America Pharmaceuticals and Biotechnology R&D Revenue by Country (2023-2028) & (USD Million)
Table 125. Middle East & Africa Pharmaceuticals and Biotechnology R&D Revenue by Type (2017-2022) & (USD Million)
Table 126. Middle East & Africa Pharmaceuticals and Biotechnology R&D Revenue by Type (2023-2028) & (USD Million)
Table 127. Middle East & Africa Pharmaceuticals and Biotechnology R&D Revenue by Application (2017-2022) & (USD Million)
Table 128. Middle East & Africa Pharmaceuticals and Biotechnology R&D Revenue by Application (2023-2028) & (USD Million)
Table 129. Middle East & Africa Pharmaceuticals and Biotechnology R&D Revenue by Country (2017-2022) & (USD Million)
Table 130. Middle East & Africa Pharmaceuticals and Biotechnology R&D Revenue by Country (2023-2028) & (USD Million)
LIST OF FIGURES
Figure 1. Pharmaceuticals and Biotechnology R&D Picture
Figure 2. Global Pharmaceuticals and Biotechnology R&D Revenue Market Share by Type in 2021
Figure 3. Drug
Figure 4. Medical Equipment
Figure 5. Vaccine
Figure 6. Others
Figure 7. Pharmaceuticals and Biotechnology R&D Revenue Market Share by Application in 2021
Figure 8. Hospital Picture
Figure 9. Clinic Picture
Figure 10. Homecare Picture
Figure 11. Others Picture
Figure 12. Global Pharmaceuticals and Biotechnology R&D Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 13. Global Pharmaceuticals and Biotechnology R&D Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Pharmaceuticals and Biotechnology R&D Revenue Market Share by Region (2017-2028)
Figure 15. Global Pharmaceuticals and Biotechnology R&D Revenue Market Share by Region in 2021
Figure 16. North America Pharmaceuticals and Biotechnology R&D Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Europe Pharmaceuticals and Biotechnology R&D Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Asia-Pacific Pharmaceuticals and Biotechnology R&D Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. South America Pharmaceuticals and Biotechnology R&D Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Middle East and Africa Pharmaceuticals and Biotechnology R&D Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Pharmaceuticals and Biotechnology R&D Market Drivers
Figure 22. Pharmaceuticals and Biotechnology R&D Market Restraints
Figure 23. Pharmaceuticals and Biotechnology R&D Market Trends
Figure 24. ROCHE Recent Developments and Future Plans
Figure 25. JOHNSON & JOHNSON Recent Developments and Future Plans
Figure 26. MERCK Recent Developments and Future Plans
Figure 27. NOVARTIS Recent Developments and Future Plans
Figure 28. PFIZER Recent Developments and Future Plans
Figure 29. SANOFI Recent Developments and Future Plans
Figure 30. BAYER Recent Developments and Future Plans
Figure 31. BRISTOL-MYERS SQUIBB Recent Developments and Future Plans
Figure 32. ASTRAZENECA Recent Developments and Future Plans
Figure 33. GLAXOSMITHKLINE Recent Developments and Future Plans
Figure 34. ABBVIE Recent Developments and Future Plans
Figure 35. ELI LILLY Recent Developments and Future Plans
Figure 36. BOEHRINGER SOHN Recent Developments and Future Plans
Figure 37. AMGEN Recent Developments and Future Plans
Figure 38. GILEAD SCIENCES Recent Developments and Future Plans
Figure 39. TAKEDA PHARMACEUTICAL Recent Developments and Future Plans
Figure 40. NOVO NORDISK Recent Developments and Future Plans
Figure 41. BIOGEN Recent Developments and Future Plans
Figure 42. ABBOTT Recent Developments and Future Plans
Figure 43. ASTELLAS PHARMA Recent Developments and Future Plans
Figure 44. TEVA PHARMACEUTICAL INDUSTRIES Recent Developments and Future Plans
Figure 45. Global Pharmaceuticals and Biotechnology R&D Revenue Share by Players in 2021
Figure 46. Pharmaceuticals and Biotechnology R&D Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 47. Global Top 3 Players Pharmaceuticals and Biotechnology R&D Revenue Market Share in 2021
Figure 48. Global Top 10 Players Pharmaceuticals and Biotechnology R&D Revenue Market Share in 2021
Figure 49. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 50. Global Pharmaceuticals and Biotechnology R&D Revenue Share by Type in 2021
Figure 51. Global Pharmaceuticals and Biotechnology R&D Market Share Forecast by Type (2023-2028)
Figure 52. Global Pharmaceuticals and Biotechnology R&D Revenue Share by Application in 2021
Figure 53. Global Pharmaceuticals and Biotechnology R&D Market Share Forecast by Application (2023-2028)
Figure 54. North America Pharmaceuticals and Biotechnology R&D Sales Market Share by Type (2017-2028)
Figure 55. North America Pharmaceuticals and Biotechnology R&D Sales Market Share by Application (2017-2028)
Figure 56. North America Pharmaceuticals and Biotechnology R&D Revenue Market Share by Country (2017-2028)
Figure 57. United States Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Canada Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Mexico Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Europe Pharmaceuticals and Biotechnology R&D Sales Market Share by Type (2017-2028)
Figure 61. Europe Pharmaceuticals and Biotechnology R&D Sales Market Share by Application (2017-2028)
Figure 62. Europe Pharmaceuticals and Biotechnology R&D Revenue Market Share by Country (2017-2028)
Figure 63. Germany Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. France Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. United Kingdom Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Russia Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Italy Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Asia-Pacific Pharmaceuticals and Biotechnology R&D Sales Market Share by Type (2017-2028)
Figure 69. Asia-Pacific Pharmaceuticals and Biotechnology R&D Sales Market Share by Application (2017-2028)
Figure 70. Asia-Pacific Pharmaceuticals and Biotechnology R&D Revenue Market Share by Region (2017-2028)
Figure 71. China Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Japan Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. South Korea Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. India Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Southeast Asia Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Australia Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South America Pharmaceuticals and Biotechnology R&D Sales Market Share by Type (2017-2028)
Figure 78. South America Pharmaceuticals and Biotechnology R&D Sales Market Share by Application (2017-2028)
Figure 79. South America Pharmaceuticals and Biotechnology R&D Revenue Market Share by Country (2017-2028)
Figure 80. Brazil Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Argentina Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Middle East and Africa Pharmaceuticals and Biotechnology R&D Sales Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Pharmaceuticals and Biotechnology R&D Sales Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Pharmaceuticals and Biotechnology R&D Revenue Market Share by Country (2017-2028)
Figure 85. Turkey Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 86. Saudi Arabia Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 87. UAE Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 88. Methodology
Figure 89. Research Process and Data Source
Figure 1. Pharmaceuticals and Biotechnology R&D Picture
Figure 2. Global Pharmaceuticals and Biotechnology R&D Revenue Market Share by Type in 2021
Figure 3. Drug
Figure 4. Medical Equipment
Figure 5. Vaccine
Figure 6. Others
Figure 7. Pharmaceuticals and Biotechnology R&D Revenue Market Share by Application in 2021
Figure 8. Hospital Picture
Figure 9. Clinic Picture
Figure 10. Homecare Picture
Figure 11. Others Picture
Figure 12. Global Pharmaceuticals and Biotechnology R&D Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 13. Global Pharmaceuticals and Biotechnology R&D Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Pharmaceuticals and Biotechnology R&D Revenue Market Share by Region (2017-2028)
Figure 15. Global Pharmaceuticals and Biotechnology R&D Revenue Market Share by Region in 2021
Figure 16. North America Pharmaceuticals and Biotechnology R&D Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Europe Pharmaceuticals and Biotechnology R&D Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Asia-Pacific Pharmaceuticals and Biotechnology R&D Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. South America Pharmaceuticals and Biotechnology R&D Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Middle East and Africa Pharmaceuticals and Biotechnology R&D Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Pharmaceuticals and Biotechnology R&D Market Drivers
Figure 22. Pharmaceuticals and Biotechnology R&D Market Restraints
Figure 23. Pharmaceuticals and Biotechnology R&D Market Trends
Figure 24. ROCHE Recent Developments and Future Plans
Figure 25. JOHNSON & JOHNSON Recent Developments and Future Plans
Figure 26. MERCK Recent Developments and Future Plans
Figure 27. NOVARTIS Recent Developments and Future Plans
Figure 28. PFIZER Recent Developments and Future Plans
Figure 29. SANOFI Recent Developments and Future Plans
Figure 30. BAYER Recent Developments and Future Plans
Figure 31. BRISTOL-MYERS SQUIBB Recent Developments and Future Plans
Figure 32. ASTRAZENECA Recent Developments and Future Plans
Figure 33. GLAXOSMITHKLINE Recent Developments and Future Plans
Figure 34. ABBVIE Recent Developments and Future Plans
Figure 35. ELI LILLY Recent Developments and Future Plans
Figure 36. BOEHRINGER SOHN Recent Developments and Future Plans
Figure 37. AMGEN Recent Developments and Future Plans
Figure 38. GILEAD SCIENCES Recent Developments and Future Plans
Figure 39. TAKEDA PHARMACEUTICAL Recent Developments and Future Plans
Figure 40. NOVO NORDISK Recent Developments and Future Plans
Figure 41. BIOGEN Recent Developments and Future Plans
Figure 42. ABBOTT Recent Developments and Future Plans
Figure 43. ASTELLAS PHARMA Recent Developments and Future Plans
Figure 44. TEVA PHARMACEUTICAL INDUSTRIES Recent Developments and Future Plans
Figure 45. Global Pharmaceuticals and Biotechnology R&D Revenue Share by Players in 2021
Figure 46. Pharmaceuticals and Biotechnology R&D Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 47. Global Top 3 Players Pharmaceuticals and Biotechnology R&D Revenue Market Share in 2021
Figure 48. Global Top 10 Players Pharmaceuticals and Biotechnology R&D Revenue Market Share in 2021
Figure 49. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 50. Global Pharmaceuticals and Biotechnology R&D Revenue Share by Type in 2021
Figure 51. Global Pharmaceuticals and Biotechnology R&D Market Share Forecast by Type (2023-2028)
Figure 52. Global Pharmaceuticals and Biotechnology R&D Revenue Share by Application in 2021
Figure 53. Global Pharmaceuticals and Biotechnology R&D Market Share Forecast by Application (2023-2028)
Figure 54. North America Pharmaceuticals and Biotechnology R&D Sales Market Share by Type (2017-2028)
Figure 55. North America Pharmaceuticals and Biotechnology R&D Sales Market Share by Application (2017-2028)
Figure 56. North America Pharmaceuticals and Biotechnology R&D Revenue Market Share by Country (2017-2028)
Figure 57. United States Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Canada Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Mexico Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Europe Pharmaceuticals and Biotechnology R&D Sales Market Share by Type (2017-2028)
Figure 61. Europe Pharmaceuticals and Biotechnology R&D Sales Market Share by Application (2017-2028)
Figure 62. Europe Pharmaceuticals and Biotechnology R&D Revenue Market Share by Country (2017-2028)
Figure 63. Germany Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. France Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. United Kingdom Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Russia Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Italy Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Asia-Pacific Pharmaceuticals and Biotechnology R&D Sales Market Share by Type (2017-2028)
Figure 69. Asia-Pacific Pharmaceuticals and Biotechnology R&D Sales Market Share by Application (2017-2028)
Figure 70. Asia-Pacific Pharmaceuticals and Biotechnology R&D Revenue Market Share by Region (2017-2028)
Figure 71. China Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Japan Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. South Korea Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. India Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Southeast Asia Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Australia Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South America Pharmaceuticals and Biotechnology R&D Sales Market Share by Type (2017-2028)
Figure 78. South America Pharmaceuticals and Biotechnology R&D Sales Market Share by Application (2017-2028)
Figure 79. South America Pharmaceuticals and Biotechnology R&D Revenue Market Share by Country (2017-2028)
Figure 80. Brazil Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Argentina Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Middle East and Africa Pharmaceuticals and Biotechnology R&D Sales Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Pharmaceuticals and Biotechnology R&D Sales Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Pharmaceuticals and Biotechnology R&D Revenue Market Share by Country (2017-2028)
Figure 85. Turkey Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 86. Saudi Arabia Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 87. UAE Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 88. Methodology
Figure 89. Research Process and Data Source
